ראשי » מאמר » Blinatumomab approved as consolidation therapy for MRD-negative B-cell precursor acute lymphoblastic leukemia Blinatumomab approved as consolidation therapy for MRD-negative B-cell precursor acute lymphoblastic leukemia תאריך: 14/11/2024 CANCER. 2024 Nov 1;130(21):3622. doi: 10.1002/cncr.35579. https://pubmed.ncbi.nlm.nih.gov/39382254/